In 1985, Arber and Sawyer described the discretionary rationing power of general practice receptionists. Our paper revisits this territory. Much has changed in the intervening decades. Digitalisation...

Find out how social scientists in our department are shaping primary health care through collaborative, theory-driven research. From digital health to health inequalities, their research helps shape p...

OSCAR is a National Applied Research Collaboration (ARC) project funded by the National Institute for Health Research (NIHR), and sponsored by the University of Oxford.

The latest Household Below Average Income (HBAI) statistics show that poverty continues to affect millions of children in the UK, with 4.5 million affected by poverty during 2023-2024, an increase of 100,00 on the year before. These figures should shame us all, and must be examined alongside the UK Government’s proposals to take £4.8 billion in social security support from some of the most vulnerable, and indeed poorest, among us. The Government’s own Impact Assessment suggests that 50,000 more children will be pulled into relative poverty as a direct result of these changes. But another way is possible. For the past five years, almost 200 parents and carers living on a low-income from all four nations of the UK have been working alongside researchers at the University of York and Child Poverty Action Group to document everyday life in poverty and to push for change. The project started life as Covid Realities in the pandemic and became Changing Realities in a cost-of-living crisis that has never gone away. In our work together, we have contributed real-time evidence to policymakers, challenged harmful media narratives, and developed co-produced recommendations for change.

New UK-wide Centre for Applied Respiratory Research, Innovation and Impact (CARRii) launches at Oxford, aiming to reduce hospital admissions and health inequalities in respiratory care through innovat...

New research shows concerning disparities in how Sotrovimab - a COVID-19 treatment approved for extremely clinically vulnerable patients - is given to patients, despite it being safe.